Pfizer Arthritis Drug Meets Goal In Second Trial - Wall Street Journal

Reuters

Pfizer Arthritis Drug Meets Goal In Second Trial Wall Street Journal Tofacitinib, which was formerly known as tasocitinib, may be a convenient, oral-pill alternative to a widely used class of rheumatoid-arthritis drugs known as anti-TNFs, which are injected or infused intravenously. Anti-TNFs include Abbott ... Pfizer's Biggest Shot at Lipitor 2.0Motley Fool all 78 news articles »

Pfizer Needs Rheumatoid Arthritis Drug to Keep Performing - Seeking Alpha

Pfizer Needs Rheumatoid Arthritis Drug to Keep Performing Seeking Alpha Success in a second pivotal study with tofacitinib, a novel pill to treat rheumatoid arthritis, is great news for Pfizer (PFE). The drug is by far the most valuable product in the pharma giant's pipeline and represents a rare home-grown compound for ... and more »

Study Finds Arthritis Patients Suffer From Poor Sleep - WDUQNews (blog)

Study Finds Arthritis Patients Suffer From Poor Sleep WDUQNews (blog) A recent study performed by the University of Pittsburgh School of Nursing found that those affected by Rheumatoid Arthritis often experience very poor sleep quality which can translate to increased symptoms and poor life quality. The study used a ... and more »

XOMA Reports 2010 and Fourth Quarter Financial Results - GlobeNewsWire (press release)

XOMA Reports 2010 and Fourth Quarter Financial Results GlobeNewsWire (press release) XOMA technologies have contributed to the success of marketed antibody products including LUCENTIS® for wet age-related macular degeneration and CIMZIA® for rheumatoid arthritis and Crohn's disease. XOMA's fully integrated product development ... and more »